AUTHOR=Zhang Ling , Chen Shan , Lin Yang , Wang Jianbin , Qiu Xinyi , Li Lizhi 

TITLE=Comparative study of robotic-assisted single-incision-plus-one port and single-incision laparoscopic choledochal cyst excision

JOURNAL=Frontiers in Pediatrics

VOLUME=12

YEAR=2024

URL=https://www.frontiersin.org/journals/pediatrics/articles/10.3389/fped.2024.1403358

DOI=10.3389/fped.2024.1403358

ISSN=2296-2360

ABSTRACT=<sec><title>Objective</title><p>To compare the efficacy of robotic-assisted single-incision-plus-one-port laparoscopic choledochal cyst excision (R-SILC + 1) and single-incision laparoscopic choledochal cyst (SILC) in treating pediatric choledochal cyst (CDC).</p></sec><sec><title>Methods</title><p>We retrospectively analyzed the clinical data of patients diagnosed with CDC in our hospital from June 2021 to October 2023. Among them, patients underwent either R-SILC + 1 or SILC procedures. Demographic parameters, operative details, and postoperative outcomes were studied.</p></sec><sec><title>Results</title><p>A total of forty-nine patients were included, with 23 children undergoing R-SILC + 1 and 26 children undergoing SILC. There were no statistically significant differences in demographic data, postoperative pain scores, and postoperative complication rates between the two groups (all <italic>p</italic> &gt; 0.05). Compared with the SILC group, the R-SILC + 1 group demonstrated less intraoperative bleeding volume (10.4 ± 3.6 vs. 15.0 ± 3.6 ml, <italic>p</italic> &lt; 0.05), a shorter indwelling time of the abdominal drainage tube [5(5,6) vs. 7(5.8,8.3) d, <italic>p</italic> &lt; 0.05], a shorter postoperative fasting time [4(3,4) vs. 6(5,7) d, <italic>p</italic> &lt; 0.05], and a shorter postoperative discharge time [6(6,7) vs. 8(6,11) d, <italic>p</italic> &lt; 0.05]. However, the R-SILC + 1 group had a longer operation time [388(295,415) vs. 341(255.8,375.2) min, <italic>p</italic> &lt; 0.05] and higher hospitalization cost (7.9 ± 0.4 vs. 3.2 ± 0.3 ten thousand, <italic>p</italic> &lt; 0.05).</p></sec><sec><title>Conclusion</title><p>Compared with the SILC group, the R-SILC + 1 group demonstrated clear advantages in treating pediatric CDC, but it is associated with a prolonged learning curve and operation time, and high costs. With improvements in physician experience and technological advancements, its potential will be further unleashed.</p></sec>